The cross-talk between the liver and SM in the IR setting is of crucial relevance, given the high prevalence of NAFLD and the reciprocal impact of insulin-sensitive tissues on the overall disease burden. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.